India: Zeon Lifesciences, a leading Contract Development and Manufacturing Organization (CDMO) specializing in nutraceuticals and ayurvedic products, is pleased to announce the appointment of Mr. GK Sharma as its Group Technical Director. With over 30 years of experience in the pharmaceutical industry, Mr. Sharma brings a wealth of expertise in optimizing manufacturing processes for fermentation-based APIs and sterile injectables.
Having held key leadership positions at industry giants such as Mylan and Ranbaxy, Mr. Sharma has successfully navigated complex regulatory landscapes, including FDA, WHO, and ANVISA, ensuring seamless compliance and operational efficiency. His ability to incubate and integrate new technologies will play a pivotal role in advancing Zeon Lifesciences’ manufacturing capabilities and innovation-driven initiatives.
Commenting on the appointment, Mr. Suresh Garg, Founder and CMD of Zeon Lifesciences, said, “We are delighted to welcome Mr. GK Sharma to the Zeon Lifesciences leadership team. His vast experience and deep technical acumen will be instrumental in strengthening our production efficiencies and reinforcing our commitment to high-quality, compliant, and innovative healthcare solutions. As we continue to expand our footprint, his expertise will drive transformative advancements in our operations.”
In his new role, Mr. Sharma will focus on enhancing process efficiencies, maintaining regulatory compliance, and spearheading research-driven advancements within Zeon Lifesciences’ manufacturing ecosystem. His leadership will be crucial as the company continues to push boundaries in nutraceuticals and ayurvedic products, ensuring superior product quality and sustainable growth. Zeon Lifesciences looks forward to leveraging his expertise to elevate its technical and operational excellence.